首页>
外国专利>
METHODS FOR PRODUCING IN VITRO WILSON'S DISEASE MODEL USING HUMAN PLURIPOTENT STEM CELL AND IN VITRO WILSON'S DISEASE MODEL PRODUCED BY THEREOF
METHODS FOR PRODUCING IN VITRO WILSON'S DISEASE MODEL USING HUMAN PLURIPOTENT STEM CELL AND IN VITRO WILSON'S DISEASE MODEL PRODUCED BY THEREOF
The present invention relates to a method for generating in vitro cultured hepatocytes using an endoplasmic reticulum stress reliever, comprising: step A of preparing a guide RNA having a nucleotide sequence of SEQ ID NO: 1; Step B of inserting the guide RNA prepared through step A into a Cas9 Nuclease expression-capable vector to prepare a vector for CRISPR/Cas9 cloned to contain the guide RNA prepared through step A; Step C of preparing ssODNs (Single Stranded Oligodeoxynucleotides) having the nucleotide sequence of SEQ ID NO: 2; Step D of injecting the vector for CRISPR/Cas9 prepared through step B and the ssODNs prepared through step C into human pluripotent stem cells; E step of culturing human pluripotent stem cells injected with the CRISPR/Cas9 vector and ssODNs through the D step to obtain a plurality of single colonies; And by performing sequencing for each of a plurality of single colonies obtained through the E step, the Wilson disease causative gene ATP7B modified to the R778L mutant through specific gene mutations, so that the onset of Wilson's disease is possible. It includes; F step of selecting a single colony with induced human pluripotent stem cells.
展开▼
机译:本发明涉及一种使用内质网应激缓解剂产生体外培养的肝细胞的方法,其包括:制备具有SEQ ID NO:1的核苷酸序列的指导RNA的步骤A;步骤B:将通过步骤A制备的指导RNA插入具有Cas9核酸酶表达能力的载体中,以制备用于CRISPR / Cas9的载体,该载体被克隆以包含通过步骤A制备的指导RNA;步骤C,制备核苷酸序列为SEQ ID NO:2的ssODNs(单链寡脱氧核苷酸);步骤D:将通过步骤B制备的CRISPR / Cas9载体和通过步骤C制备的ssODNs注射入人多能干细胞中; E步骤,通过D步骤培养注射了CRISPR / Cas9载体和ssODN的人多能干细胞,以获得多个单菌落;并且,通过对通过E步骤获得的多个单个菌落中的每一个进行测序,通过特定的基因突变将威尔逊病的致病基因ATP7B修饰为R778L突变体,从而使得威尔逊病的发作成为可能。这包括;选择具有诱导的人多能干细胞的单个菌落的F步骤。
展开▼